SPEEDX-PTY-LTD
SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has signed a collaborative agreement with GSK, to provide a combination of existing tests and custom test development to support certain GSK antibiotic clinical trials and new product development.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190624005302/en/
“We welcome this extension of the utility and application of our tests and technology,” said Colin Denver, SpeeDx CEO. “SpeeDx has a demonstrated commitment to improve patient care, and our tests currently used in clinical practice are supporting Resistance Guided Therapy, positively impacting cure rates and helping to minimise the spread of antimicrobial resistant infections.”
About SpeeDx
Founded in 2009, SpeeDx is an Australian-based private company with offices in Austin and London, and distributors across Europe. SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. Innovative real-time polymerase chain reaction (qPCR) technology has driven market-leading multiplex detection and priming strategies. Product portfolios focus on multiplex diagnostics for sexually transmitted infection (STI), antibiotic resistance markers, and respiratory disease. For more information about SpeeDx please see: https://plexpcr.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20190624005302/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CA-RASA23.4.2024 12:04:29 CEST | Press release
Rasa Recognized as a Representative Vendor in Gartner® Market Guide for Conversational AI Solutions
MA-BEIGENE23.4.2024 12:01:29 CEST | Press release
BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
SAMSUNG-ELECTRONICS23.4.2024 10:44:26 CEST | Press release
Samsung Electronics Begins Industry's First Mass Production of 9th-Gen V-NAND
IL-SHIPPEO23.4.2024 10:40:26 CEST | Press release
Shippeo Spring Platform Release Reveals All-new Parcel Tracking, Advanced Carbon Emissions Monitoring Features, and Enhanced Container Tracking Data Quality
JAPAN-PRIZE-FOUNDATION23.4.2024 09:32:34 CEST | Press release
The 2024 Japan Prize Award Ceremony Is Held with Their Majesties the Emperor and Empress of Japan in Attendance
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom